Professional Documents
Culture Documents
SV - Topic 3 - IFRS 2 Thanh Toán Trên Cơ S CP
SV - Topic 3 - IFRS 2 Thanh Toán Trên Cơ S CP
Chapter 13
Share-based
Payment
1
12/9/2022
Learning Objectives
Content
1. Introduction
2. Equity-settled Share-based Transactions
3. Cash-settled Share-based Transactions
4. Share-based Payment Arrangements with a Cash
Alternative
2
12/9/2022
ESOP:
Fixed share option plans
Restricted performance share option plans
Share appreciation rights
Examples
3
12/9/2022
Share-based transactions
Grant Date
Measurement
Date
Vesting
Date
Non-
vesting Vesting
Condition Reload
Condition Feature
Forfeiture FV @ Intrinsic
Rate Grant Date Value
4
12/9/2022
5
12/9/2022
11
Terminology
Vesting period
6
12/9/2022
Illustration 13.1
Capital Corpration Ltd (CCL), a listed company, introduced a share option scheme
called the CCL share Option Scheme on 1/1/20X1. All managers accepted the terms of
the share option scheme on 5 January 20X1. Under the scheme, ten key managers
were garanted 100.000 share options each. Each option entiled the grantee to take up on
ordinary share in the company. The options could be exercised at any time after two
years (during which time the employee must not leave the entity), but no later than the
expiry date, which was 5 January 20X6. The exercise price was $2 per share, which
was the actual market price on the date of the grant.
Other information and assumptions are as follows:
a) At the date of the grant, the estimated fair value of the share option was $0.4 per
option. CCL estimated that two out of the ten managers would leave the entity
before 5 January 20X3.
b) One of the managers left the company in 20X1. At the end of 20X1, CCL increased
its estimate of the number of managers leaving the company from two to three.
c) In 20X2, another manager left CCL
d) On 15 January 20X3, all of the remaining managers exercised their share option
when the market price of CCL’s share was $ 2,8.
e) CCL’s financial year-end is 31 December.
Require: Calculate the remuneration expenses over vesting period 13
Content
1. Introduction
2. Equity-settled Share-based Transactions
3. Cash-settled Share-based Transactions
4. Share-based Payment Arrangements with a Cash
Alternative
14
7
12/9/2022
16
8
12/9/2022
Note
• FV at grant date
= current market price – PV(exercise price) –
FV of dividends (that will not receiveed during the
vesting period)
• Instrinsic value
= Market value at Xi – Exercise price at Xi
Tham khảo
17
- Giao dịch được thanh toán bằng cổ phiếu của doanh nghiệp
- Đo lường: FV của option/right… vào ngày đảm bảo (grant
date)
- Cuối mỗi kỳ báo cáo:
- Ước tính số dư lũy kế giá trị giao dịch
- Xác định chi phí ghi nhận cho kỳ kế toán và ghi nhận:
18
9
12/9/2022
20
10
12/9/2022
Vesting period
11
12/9/2022
10 CEO
2 Years
5/1/X6
100.000 Options/CEO 15/1/X3 Exercise date
V date:5/1/X3
Strick price: 2$/CP
31/12/X1 31/12/X2
5/1/X1 1 CEO 1 CEO
31/12/20X1:
31/12/20X2:
23
On 1 Nov 20X0, Alto Corporation announced a share incentive plan for 100
executives. The terms of plan are as follows:
a) The number of options each executive would receive was given by following
formula: 50.000 * (1+ simple average annual rate of increase in net earnings
from 1/1/20X1 to 31/12/20X3). An encrease in net earnings is a performance
condition. IFRS 2 allows the performance target to ralate to entity as a whole or a
part of the entity, such as a division. A reference to a share index is a non- vesting
codition and not a performance condition.
b) The exercise price was $ 3,6 per share, which was the same as the market price
(share) on grant date.
c) The options were not transferable, they were exercisable three years from the
grant date. The options expired at the end of five years from the grant date.
d) The options would be forfeited should any manager leave the entity during the
service period of three years.
e) The estimated fair value of the share option at grant date was $0.50.
24
12
12/9/2022
- The plan was approved by sharehoders on 1 Jan 20X1. AT the date of the grant of
the share option, the management of Alto Corporation estimated that the company’s
net earnings would increase by 10% a year. Management also estimated a forfeiture
rate at of 10%, that is, 10% of the excusive would leave the company by the end of
20X3.
- At the end 20X1, the net earnings of Alto increseased by 15% over 20X0. Three
execusives left the company in 20X1. Management revised the forfeiture rate to
8% by the end of 20X3, and net earnings were revised to grow by an average of
12% for the three-year period.
-In 20X2, two execusives left the company and net earnings increased by 8% over
20X1. Management retained its estimate of the forfeiture rate at 8% and estimeted
net earnings to grow by an average of 10% over the three-year period.
-In 20X3, two execusives left the company and net earnings insreased by 13% over
20X2, resulting in a simple average annual increase of 12% for the 20x1 to 20X3
period. On the 31 Dec 20X3, the share price of Alto was $ 5 and all remaining
executives exercised the options granted to them under the performance-based
scheme.
25
31.Dec.X2
31.Dec.X3
The journal entries:
31/12/20X1:
31/12/20X2:
31/12/20X3:
15/1/20X4:
26
13
12/9/2022
Note
27
Increase Reduce
Reduction of exercise price,
Prolong vesting period, increase
increase in number of equity
exercise price,..
instrument,…
28
14
12/9/2022
Any
• Should be recognized immediately
unrecognized
amount
29
30
15
12/9/2022
On 1 Jan 20X1, Reford Corporation, a listed company, granted 30.000 share options
to each of its 100 employees. The options were exercisable three years from the date
of the grant, conditional upon the employee remaining in the entity’s employment
during the three- year service period. The option would expire ten years after the date
of the grant. The exercise price was $3, which was also the market price at the grant
date. The fair value of each share option was estimated at $ 1,5 at the grant date.
Management estimated a forfeiture rate of 10% over three years, that is, a total of ten
employees were estimated to leave the entity by the end of 20X3. Five employees left
during 20X1, but no adjustment was made to the forfeiture rate at the end 20X1.
Another five employees left the entity during 20X2. At the end of 20X2, management
revised the forfeiture rate of 15%. Two employees left in 20X3.
At 1 Jan 20X2, the market price of Reford Corporation share fell to $2,2. Reford
Corporation revised the exercise price to $ 2,2. At this date, the fair value of the
original option before repricing was estimated at $1; the fair value of the modified
option was estimated at $1.3.
31
Content
1. Introduction
2. Equity-settled Share-based Transactions
3. Cash-settled Share-based Transactions
4. Share-based Payment Arrangements with a Cash
Alternative
32
16
12/9/2022
• Entity incurs liability for the services received from the employees
– Measured initially and remeasured at each reporting date to
settlement date
– Fair value estimated using option valuation model (IFRS 13- FV)
– Changes in fair value goes to profit and loss
33
34
17
12/9/2022
35
18
12/9/2022
The fair values and instrinsic values of the SARs over the vesting period are as follows:
(1)The entity pays cash in return for (2)The entity issues shares in return
the provision of goods or services for the provision of goods or
DR- Asset/(P/L)- Expense services
CR Liability DR- (P/L) )- Expense
CR Equity
(3) There’s also the third type of share-based payment arrangements: transactions
in which either the entity or the supplier has a choice of settlement (to receive
equity instruments or cash / other assets).
38
19
12/9/2022
Content
1. Introduction
2. Equity-settled Share-based Transactions
3. Cash-settled Share-based Transactions
4. Share-based Payment Arrangements with a Cash
Alternative
39
40
20
12/9/2022
41
(1) Liability
Account as cash-settled
Yes
share-based transaction
Obligation to
(i) Repurchase
settle in cash Repurchase of
Excess of FV of
equity (cash
Settle in cash equity -> expense
paid - FV of
equity)
No (ii) Issue share
(2) Equity
Issue equity No further Excess of FV of
instruments accounting equity -> expense
42
21
12/9/2022
43
Scenario 1: Settlement in cash, cash settlement has higher value than shares :
• At the end of year 2, Z chooses to settle in cash $ 110.000:
44
22
12/9/2022
Example
Scenario 2: Settlement in equity, cash settlement has higher value than
shares :
• At the end of year 2, Z chooses to settle in equity $ 100.000:
45
Example
Scenario 3: Settlement in cash, cash settlement has lower value than
shares :
Z has a choice to settle its employee options in cash $90.000 or shares.
The is no present obligation and no past practice to settle in cash. On
grant date, the equity value is $ 100.000.
• At the end of year 2, Z chooses to settle in cash $ 90.000:
46
23
12/9/2022
Example
47
48
24
12/9/2022
Measurement
Vesting Period Settlement Date
Date
Same as equity-settled
Difference in fair Remains in equity, no
share-based payment
value of “equity reverse, but is
Equity transactions and
alternative” and transferable from one
re-measured and recognized
“cash alternative” component to another
in equity
49
The share prices of Delta Corporation at the end of 20X3 and 20X4 were $3,3 and
$3,6 respectively. Assume the following share price at the end of 20X5
Situation 1: The share price of of Delta Corporation at the end of 20X5 was $3,8
50
Situation 2: The share price of of Delta Corporation at the end of 20X5 was $4,5
25
12/9/2022
51
Situation 2: The share price of of Delta Corporation at the end of 20X5 was $4,5
Cash alternative
Share option (Instrinsic value)
Difference in favour of the equity alternative
52
26
12/9/2022
Situation 1: The share price of of Delta Corporation at the end of 20X5 was $3,8
53
Situation 1: The share price of of Delta Corporation at the end of 20X5 was $3,8
54
27
12/9/2022
Situation 2: The share price of of Delta Corporation at the end of 20X5 was $4,5
55
56
28